➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
AstraZeneca
Colorcon
Baxter
Medtronic

Last Updated: April 17, 2021

DrugPatentWatch Database Preview

Asparaginase - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for asparaginase

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Hunan Cancer HospitalPhase 2
Fundação Rui Osório de CastroPhase 3
The Swedish Research CouncilPhase 3

See all asparaginase clinical trials

Recent Litigation for asparaginase

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Highland Capital Management, L.P. v. Dondero2021-01-21
Ravgen, Inc. v. Progenity, Inc.2020-12-20
Ravgen, Inc. v. Myriad Genetics, Inc.2020-12-20

See all asparaginase litigation

PTAB Litigation
PetitionerDate
2017-11-17
2016-09-09
2013-01-28

See all asparaginase litigation

Patent Text Search: US Patents for asparaginase

These patents were identified by searching patent claims

Supplementary Protection Certificates for asparaginase

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0047 Belgium   Start Trial PRODUCT NAME: DOXORUBICIN HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/96/011/001 19960624
2007 00027 Denmark   Start Trial PRODUCT NAME: PERFLUTREN-HOLDIGE LIPIDMIKROSAERER
2007000024 Germany   Start Trial PRODUCT NAME: PERFLUTREN ENTHALTENDE LIPID-MIKROPARTIKEL; REGISTRATION NO/DATE: EU/1/06/361/001 20060920
0031 Netherlands   Start Trial 960031, 20101020, EXPIRES: 20110620
C018/2007 Ireland   Start Trial SPC018/2007: 20071012, EXPIRES: 20190519
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Harvard Business School
Mallinckrodt
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.